|Bid||16.61 x 1400|
|Ask||17.00 x 800|
|Day's Range||16.67 - 17.34|
|52 Week Range||4.96 - 18.07|
|Beta (5Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 01, 2021 - Nov. 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.00|
NEW YORK, October 04, 2021--Iveric Bio granted equity-based awards pursuant to the Company's 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.
In this article we are going to estimate the intrinsic value of IVERIC bio, Inc. ( NASDAQ:ISEE ) by taking the forecast...
NEW YORK, September 10, 2021--Iveric announced that Pravin Dugel, M.D., President, will present an overview of the Company at the 2021 H.C. Wainwright Global Investment Conference.